<?xml version="1.0" encoding="UTF-8"?><rss version="2.0">
    <channel>
    <title>PMLiVE RSS Feed: News RSS</title>
 <link>http://www.pmlive.com</link>
        <description>PMLiVE RSS Feed: News RSS</description>
        <language>en-gb</language>
<image>
<url>http://www.pmlive.com/__data/assets/thumbnail/0003/70842/feed-icon-28x28.png</url>
    <title>PMLiVE RSS Feed: News RSS</title>
 <link>http://www.pmlive.com</link>
</image>
        
		<item>
  <title>Bayer's Diane 35 to remain on European market</title>
  <link>http://www.pmlive.com/pharma_news/bayers_diane_35_to_remain_on_european_market_477467</link>
  <description><![CDATA[
EMA investigation concludes acne treatment's benefits outweigh its risks]]></description>
  <pubDate>Mon, 20 May 2013 00:15:33 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/bayers_diane_35_to_remain_on_european_market_477467</guid>
</item> <item>
  <title>PMEA 2013 opens for entry</title>
  <link>http://www.pmlive.com/pharma_news/pmea_2013_opens_for_entry_477427</link>
  <description><![CDATA[Programme recognises responsible marketing and business practice in the healthcare industry]]></description>
  <pubDate>Mon, 20 May 2013 00:15:15 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/pmea_2013_opens_for_entry_477427</guid>
</item> <item>
  <title>J&amp;J's Simponi wins FDA approval in ulcerative colitis</title>
  <link>http://www.pmlive.com/pharma_news/j_and_js_simponi_wins_fda_approval_in_ulcerative_colitis_477400</link>
  <description><![CDATA[Adds to rheumatoid arthritis, psoriatic arthritis and active ankylosing spondylitis indications in the US ]]></description>
  <pubDate>Fri, 17 May 2013 10:47:43 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/j_and_js_simponi_wins_fda_approval_in_ulcerative_colitis_477400</guid>
</item> <item>
  <title>Sanofi plans to file JAK2 inhibitor after positive phase III</title>
  <link>http://www.pmlive.com/pharma_news/sanofi_plans_to_file_jak2_inhibitor_after_positive_phase_iii_477410</link>
  <description><![CDATA[Aiming for approval in blood cancer myelofibrosis]]></description>
  <pubDate>Fri, 17 May 2013 10:46:53 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/sanofi_plans_to_file_jak2_inhibitor_after_positive_phase_iii_477410</guid>
</item> <item>
  <title>Bayer boosts consumer care business with Steigerwald purchase</title>
  <link>http://www.pmlive.com/pharma_news/bayer_boosts_consumer_care_business_with_steigerwald_purchase_477405</link>
  <description><![CDATA[Fuels ambition to become world leader in OTC medicines]]></description>
  <pubDate>Fri, 17 May 2013 10:29:24 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/bayer_boosts_consumer_care_business_with_steigerwald_purchase_477405</guid>
</item> <item>
  <title>NICE recommends Astellas' Betmiga for overactive bladder</title>
  <link>http://www.pmlive.com/pharma_news/nice_recommends_astellas_betmiga_for_overactive_bladder_477314</link>
  <description><![CDATA[Final draft guidance recommends Vesicare successor]]></description>
  <pubDate>Fri, 17 May 2013 00:15:42 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/nice_recommends_astellas_betmiga_for_overactive_bladder_477314</guid>
</item> <item>
  <title>Amgen and Novartis partner with biotech venture capital firm</title>
  <link>http://www.pmlive.com/pharma_news/amgen_and_novartis_partner_with_biotech_venture_capital_firm_477257</link>
  <description><![CDATA[Atlas Venture fund aims to create 15 new biotech companies]]></description>
  <pubDate>Thu, 16 May 2013 10:42:28 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/amgen_and_novartis_partner_with_biotech_venture_capital_firm_477257</guid>
</item> <item>
  <title>Merck KGaA forges clinical alliance with Quintiles</title>
  <link>http://www.pmlive.com/pharma_news/merck_kgaa_forges_clinical_alliance_with_quintiles_477251</link>
  <description><![CDATA[CRO becomes sole outsourcing partner for pharma company]]></description>
  <pubDate>Thu, 16 May 2013 10:00:50 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/merck_kgaa_forges_clinical_alliance_with_quintiles_477251</guid>
</item> <item>
  <title>FDA clears Bayer/ Algeta's prostate cancer radiotherapy</title>
  <link>http://www.pmlive.com/pharma_news/fda_clears_bayer_algetas_prostate_cancer_radiotherapy_477248</link>
  <description><![CDATA[Approval for Xofigo comes three months ahead of schedule]]></description>
  <pubDate>Thu, 16 May 2013 09:42:06 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/fda_clears_bayer_algetas_prostate_cancer_radiotherapy_477248</guid>
</item> <item>
  <title>Video for neglected tropical diseases challenges viewers</title>
  <link>http://www.pmlive.com/pharma_news/video_for_neglected_tropical_diseases_challenges_viewers_477080</link>
  <description><![CDATA[ Non-profit organisation END7 asks: 'Can you watch what they watched?' ]]></description>
  <pubDate>Thu, 16 May 2013 02:15:26 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/video_for_neglected_tropical_diseases_challenges_viewers_477080</guid>
</item> <item>
  <title>Novo Nordisk: Strict US regulation threatens innovation</title>
  <link>http://www.pmlive.com/pharma_news/novo_nordisk_strict_us_regulation_threatens_innovation_477148</link>
  <description><![CDATA[
Warning from CEO Sorensen comes after Tresiba and Ryzodeg fail to win FDA approval
]]></description>
  <pubDate>Thu, 16 May 2013 00:15:48 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/novo_nordisk_strict_us_regulation_threatens_innovation_477148</guid>
</item> <item>
  <title>From paralysis to analysis: the journey to multichannel marketing</title>
  <link>http://www.pmlive.com/pharma_news/from_paralysis_to_analysis_the_journey_to_multichannel_marketing_476741</link>
  <description><![CDATA[To make most of multichannel strategy, companies must be proactive and pull multichannel planning into the strategic process much earlier]]></description>
  <pubDate>Thu, 16 May 2013 00:15:21 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/from_paralysis_to_analysis_the_journey_to_multichannel_marketing_476741</guid>
</item> <item>
  <title>Sanofi fined for slamming Plavix generics</title>
  <link>http://www.pmlive.com/pharma_news/sanofi_fined_for_slamming_plavix_generics_477053</link>
  <description><![CDATA[Faces €40.6m penalty for telling doctors generic copies were not suitable substitutes for blockbuster antiplatelet drug]]></description>
  <pubDate>Wed, 15 May 2013 10:52:46 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/sanofi_fined_for_slamming_plavix_generics_477053</guid>
</item> <item>
  <title>FDA expands use of Roche/ Astellas’ Tarceva in lung cancer patients</title>
  <link>http://www.pmlive.com/pharma_news/fda_expands_use_of_roche_astellas_tarceva_in_lung_cancer_patients_477045</link>
  <description><![CDATA[
New indication approved alongside companion diagnostic to detect gene mutation
]]></description>
  <pubDate>Wed, 15 May 2013 10:51:18 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/fda_expands_use_of_roche_astellas_tarceva_in_lung_cancer_patients_477045</guid>
</item> <item>
  <title>Merck KGaA to meet 2014 financial targets one year early</title>
  <link>http://www.pmlive.com/pharma_news/merck_kgaa_to_meet_2014_financial_targets_one_year_early_477037</link>
  <description><![CDATA[But continued growth of Rebif under threat from new oral MS drugs]]></description>
  <pubDate>Wed, 15 May 2013 09:53:34 +0100</pubDate>
  <guid>http://www.pmlive.com/pharma_news/merck_kgaa_to_meet_2014_financial_targets_one_year_early_477037</guid>
</item>     </channel>
</rss>